Loading chat...
MD HB808
Bill
Status
Introduced
2/4/2026
Primary Sponsor
Steve Johnson
Click for details
AI Summary
- Prohibits the Maryland Medical Assistance Program (Medicaid) from imposing prior authorization requirements on prescription drugs used to treat adult enrollees diagnosed with bipolar disorder, schizophrenia, major depression, PTSD, or medication-induced movement disorders associated with serious mental illness, beginning July 1, 2026
- Bans the Program from applying step therapy or fail-first protocols for prescription drugs treating the same serious mental illness diagnoses for any enrollee, beginning July 1, 2026
- Preserves an exception for prior authorization requirements mandated under federal Medicaid law (42 U.S.C. § 1396A)
- Includes a 3-year sunset provision, automatically expiring on June 30, 2029, without further legislative action
- Introduced by Delegate S. Johnson on February 4, 2026, and assigned to the House Health Committee (cross-filed with SB 490)
Legislative Description
Maryland Medical Assistance Program - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness
Drugs
Last Action
Hearing 2/19 at 1:30 p.m.
2/19/2026
Committee Referrals
Health2/4/2026
Full Bill Text
No bill text available